Product Code: ETC190180 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The Indonesia chemical and pharmaceutical market is one of the largest in Southeast Asia. In 2025, it was estimated to be worth USD 16.8 billion and is projected to reach a value of USD 24.4 billion by 2031, registering an annual compound growth rate (CAGR) of 6.2%. This market is mainly driven by factors such as high population density; increasing disposable income levels; rising healthcare expenditure; a rapidly growing middle class; government support for R&D initiatives in the sector; and increasing global trade volumes. The Indonesia chemical and pharmaceuticals industry has also benefited from innovations related to biotechnology, nanotechnology, green chemistry, etc., which have resulted in new product launches over recent years.
There are several trends driving the growth of Indonesia chemical and pharmaceutical industry today including: Rising demand for generic drugs due to their affordability compared with branded products, increased use of active ingredients derived from natural sources or organic chemicals rather than synthetic ones, implementation of various regulations promoting responsible manufacturing processes such as ISO 9001 & 14001 standards among others. Additionally retail formats like e-commerce have become increasingly popular among consumers as they provide convenience when purchasing these products online. Furthermore there has been an increase in investments into research & development activities within this field resulting better quality medications being made available at lower prices across Indonesia population base too.
The key drivers impacting the Indonesia chemical and pharmaceutical market include improved economic conditions leading to higher disposable incomes amongst citizens which further results in greater access to healthcare services while investment incentives provided by local governments encourage foreign companies looking enter this space either through partnerships or direct investment route giving them competitive edge over domestic players operating on limited resources alone thus aiding overall development process significantly. Moreover with easy availability raw materials required production purposes coupled favorable regulatory policies place country well suited producing wide range medicines treatments both medicinal cosmetic purpose ensuring that customer requirements met efficiently cost effectively manner possible without compromising quality standards any way whatsoever.
Due to COVID-19 pandemic impacted Indonesia Chemical Pharmaceutical Market drastically because many countries imposed restrictions movement goods prevent spread virus included import export activities causing significant dip sales revenues industries related these sectors however some segments reported modest gains result efforts taken containing coronavirus example hand sanitizer producers saw unprecedented surge demand year 2025 moreover shifted focus towards manufacturing disinfectants detergents other cleaning agents responding sudden rise need occasions home offices schools places worshiping helped cushion blow somewhat still impact.
Another challenge faced by this sector is the high cost of production due to increasing input costs like energy, packaging materials etc., which makes it difficult for local manufacturers to compete with international companies who are able to benefit from lower manufacturing costs abroad. In addition, there are also quality control issues that need to be addressed if local producers are going to remain competitive on global markets.
Despite these challenges there are some key players who have been able to make headway into Indonesia booming chemicals and pharmaceutical market including: PT Kalbe Farma Tbk (KLBF), PT Indofarma Tbk (INDF), Soho Global Health Ltd., International Pharmaceutical Industries Co Ltd., Bayer AG (BAYRY) , Pfizer Inc.(PFE). These companies hold leading positions within their respective fields within Indonesia thanks largely due their investments into R&D activities resulting in higher quality products than what can typically be found elsewhere on the continent.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Chemical Pharmaceutical Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Chemical Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Chemical Pharmaceutical Market - Industry Life Cycle |
3.4 Indonesia Chemical Pharmaceutical Market - Porter's Five Forces |
3.5 Indonesia Chemical Pharmaceutical Market Revenues & Volume Share, By By Drug Type, 2021 & 2031F |
3.6 Indonesia Chemical Pharmaceutical Market Revenues & Volume Share, By By Technology, 2021 & 2031F |
3.7 Indonesia Chemical Pharmaceutical Market Revenues & Volume Share, By By End User, 2021 & 2031F |
4 Indonesia Chemical Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Chemical Pharmaceutical Market Trends |
6 Indonesia Chemical Pharmaceutical Market, By Types |
6.1 Indonesia Chemical Pharmaceutical Market, By By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By By Drug Type, 2021-2031F |
6.1.3 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Small Molecule Drugs, 2021-2031F |
6.1.4 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Biologic Drugs, 2021-2031F |
6.2 Indonesia Chemical Pharmaceutical Market, By By Technology |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By High Throughput Screening, 2021-2031F |
6.2.3 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Pharmacogenomics, 2021-2031F |
6.2.4 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Combinatorial Chemistry, 2021-2031F |
6.2.5 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Nanotechnology, 2021-2031F |
6.2.6 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Other Technologies, 2021-2031F |
6.3 Indonesia Chemical Pharmaceutical Market, By By End User |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Pharmaceutical Companies, 2021-2031F |
6.3.3 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Contract Research Organizations (CROs), 2021-2031F |
6.3.4 Indonesia Chemical Pharmaceutical Market Revenues & Volume, By Other End Users, 2021-2031F |
7 Indonesia Chemical Pharmaceutical Market Import-Export Trade Statistics |
7.1 Indonesia Chemical Pharmaceutical Market Export to Major Countries |
7.2 Indonesia Chemical Pharmaceutical Market Imports from Major Countries |
8 Indonesia Chemical Pharmaceutical Market Key Performance Indicators |
9 Indonesia Chemical Pharmaceutical Market - Opportunity Assessment |
9.1 Indonesia Chemical Pharmaceutical Market Opportunity Assessment, By By Drug Type, 2021 & 2031F |
9.2 Indonesia Chemical Pharmaceutical Market Opportunity Assessment, By By Technology, 2021 & 2031F |
9.3 Indonesia Chemical Pharmaceutical Market Opportunity Assessment, By By End User, 2021 & 2031F |
10 Indonesia Chemical Pharmaceutical Market - Competitive Landscape |
10.1 Indonesia Chemical Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Chemical Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |